| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/J.BIOCHI.2007.01.005 |
| P698 | PubMed publication ID | 17336442 |
| P50 | author | Friedemann Weber | Q40182480 |
| P2093 | author name string | Otto Haller | |
| P2860 | cites work | Inhibition of the interferon-inducible protein kinase PKR by HCV E2 protein | Q22010192 |
| Inhibition of retinoic acid-inducible gene I-mediated induction of beta interferon by the NS1 protein of influenza A virus | Q24311228 | ||
| Cardif is an adaptor protein in the RIG-I antiviral pathway and is targeted by hepatitis C virus | Q24336255 | ||
| The vaccinia virus soluble alpha/beta interferon (IFN) receptor binds to the cell surface and protects cells from the antiviral effects of IFN. | Q24527590 | ||
| The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus | Q24533256 | ||
| Influenza A virus NS1 protein targets poly(A)-binding protein II of the cellular 3'-end processing machinery | Q24534097 | ||
| ICP0 prevents RNase L-independent rRNA cleavage in herpes simplex virus type 1-infected cells | Q24535541 | ||
| Inhibition of PACT-mediated activation of PKR by the herpes simplex virus type 1 Us11 protein | Q24538727 | ||
| Dissociation of a MAVS/IPS-1/VISA/Cardif-IKKepsilon molecular complex from the mitochondrial outer membrane by hepatitis C virus NS3-4A proteolytic cleavage | Q24546084 | ||
| The V proteins of paramyxoviruses bind the IFN-inducible RNA helicase, mda-5, and inhibit its activation of the IFN-beta promoter | Q24558779 | ||
| Induction of suppressor of cytokine signaling-3 by herpes simplex virus type 1 contributes to inhibition of the interferon signaling pathway | Q24563231 | ||
| Human papillomavirus 16 E6 oncoprotein binds to interferon regulatory factor-3 and inhibits its transcriptional activity | Q24599944 | ||
| Inhibition of interferon signaling by dengue virus | Q24630622 | ||
| Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells | Q27469379 | ||
| Loss of interferon regulatory factor 3 in cells infected with classical swine fever virus involves the N-terminal protease, Npro | Q27469610 | ||
| The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans | Q45420643 | ||
| Sendai virus C protein physically associates with Stat1. | Q45736579 | ||
| Inhibition of Ran guanosine triphosphatase-dependent nuclear transport by the matrix protein of vesicular stomatitis virus | Q45762580 | ||
| Binding of the influenza virus NS1 protein to double-stranded RNA inhibits the activation of the protein kinase that phosphorylates the elF-2 translation initiation factor | Q45772727 | ||
| Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species specificity | Q45785576 | ||
| Reovirus sigma 3 protein: dsRNA binding and inhibition of RNA-activated protein kinase | Q74585528 | ||
| Characterization of viral double-stranded RNA-binding proteins | Q77293294 | ||
| NSs protein of Rift Valley fever virus blocks interferon production by inhibiting host gene transcription | Q39960501 | ||
| Hendra virus V protein inhibits interferon signaling by preventing STAT1 and STAT2 nuclear accumulation | Q40012127 | ||
| Thogoto virus lacking interferon-antagonistic protein ML is strongly attenuated in newborn Mx1-positive but not Mx1-negative mice | Q40163331 | ||
| Severe acute respiratory syndrome coronavirus open reading frame (ORF) 3b, ORF 6, and nucleocapsid proteins function as interferon antagonists | Q40208162 | ||
| The N- and C-terminal domains of the NS1 protein of influenza B virus can independently inhibit IRF-3 and beta interferon promoter activation | Q40213877 | ||
| mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. | Q40218590 | ||
| Influenza virus evades innate and adaptive immunity via the NS1 protein | Q40267847 | ||
| Attenuating mutations in the P/C gene of human parainfluenza virus type 1 (HPIV1) vaccine candidates abrogate the inhibition of both induction and signaling of type I interferon (IFN) by wild-type HPIV1. | Q40272095 | ||
| Inhibition of interferon signaling by the Kaposi's sarcoma-associated herpesvirus full-length viral interferon regulatory factor 2 protein. | Q40311533 | ||
| Inhibition of interferon signaling by rabies virus phosphoprotein P: activation-dependent binding of STAT1 and STAT2. | Q40311646 | ||
| Binding of the influenza A virus NS1 protein to PKR mediates the inhibition of its activation by either PACT or double-stranded RNA. | Q40319046 | ||
| Variation in the ability of human influenza A viruses to induce and inhibit the IFN-beta pathway. | Q40336119 | ||
| Role of double-stranded RNA and Npro of classical swine fever virus in the activation of monocyte-derived dendritic cells | Q40375175 | ||
| N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction | Q40393486 | ||
| Identification of the rabies virus alpha/beta interferon antagonist: phosphoprotein P interferes with phosphorylation of interferon regulatory factor 3. | Q40416432 | ||
| Inhibition of RNA polymerase II phosphorylation by a viral interferon antagonist | Q40554311 | ||
| The leader protein of Theiler's virus interferes with nucleocytoplasmic trafficking of cellular proteins | Q40572718 | ||
| Kaposi's sarcoma-associated herpesvirus-encoded vIRF-3 stimulates the transcriptional activity of cellular IRF-3 and IRF-7. | Q40608568 | ||
| Measles virus suppresses interferon-alpha signaling pathway: suppression of Jak1 phosphorylation and association of viral accessory proteins, C and V, with interferon-alpha receptor complex | Q40666097 | ||
| All four Sendai Virus C proteins bind Stat1, but only the larger forms also induce its mono-ubiquitination and degradation | Q40729242 | ||
| The V protein of human parainfluenza virus 2 antagonizes type I interferon responses by destabilizing signal transducer and activator of transcription 2. | Q40808240 | ||
| Nipah virus V and W proteins have a common STAT1-binding domain yet inhibit STAT1 activation from the cytoplasmic and nuclear compartments, respectively | Q40883579 | ||
| Unique properties of a second human herpesvirus 8-encoded interferon regulatory factor (vIRF-2). | Q40961025 | ||
| Vaccinia virus-encoded cytokine receptor binds and neutralizes chicken interferon-gamma | Q41012375 | ||
| Nuclear localization of the Nipah virus W protein allows for inhibition of both virus- and toll-like receptor 3-triggered signaling pathways | Q41843640 | ||
| Inhibition of the type I interferon response by the nucleoprotein of the prototypic arenavirus lymphocytic choriomeningitis virus | Q41847342 | ||
| Double-stranded RNA binding by human cytomegalovirus pTRS1. | Q42147481 | ||
| A cytomegaloviral protein reveals a dual role for STAT2 in IFN-{gamma} signaling and antiviral responses | Q42215415 | ||
| Double-stranded RNA is produced by positive-strand RNA viruses and DNA viruses but not in detectable amounts by negative-strand RNA viruses | Q42425012 | ||
| Negative regulation of the alpha interferon-induced antiviral response by the Ras/Raf/MEK pathway | Q42425053 | ||
| Inhibition of host RNA polymerase II-dependent transcription by vesicular stomatitis virus results from inactivation of TFIID. | Q42464743 | ||
| Defective translational control facilitates vesicular stomatitis virus oncolysis | Q42831942 | ||
| Inhibition of PKR by vaccinia virus: role of the N- and C-terminal domains of E3L. | Q44946042 | ||
| Double-stranded RNA binding by a heterodimeric complex of murine cytomegalovirus m142 and m143 proteins | Q38761545 | ||
| Double-stranded RNA binding of influenza B virus nonstructural NS1 protein inhibits protein kinase R but is not essential to antagonize production of alpha/beta interferon | Q39320757 | ||
| Characterization of a novel human herpesvirus 8-encoded protein, vIRF-3, that shows homology to viral and cellular interferon regulatory factors | Q39593162 | ||
| The V protein of simian virus 5 inhibits interferon signalling by targeting STAT1 for proteasome-mediated degradation | Q39596942 | ||
| Genetic evidence for an interferon-antagonistic function of rift valley fever virus nonstructural protein NSs | Q39601913 | ||
| Nipah virus V protein evades alpha and gamma interferons by preventing STAT1 and STAT2 activation and nuclear accumulation | Q39685810 | ||
| Newcastle disease virus (NDV)-based assay demonstrates interferon-antagonist activity for the NDV V protein and the Nipah virus V, W, and C proteins | Q39699288 | ||
| Regulation of the double-stranded RNA-dependent protein kinase PKR by RNAs encoded by a repeated sequence in the Epstein-Barr virus genome | Q39718117 | ||
| The STAT2 activation process is a crucial target of Sendai virus C protein for the blockade of alpha interferon signaling | Q39732576 | ||
| Degradation of STAT1 and STAT2 by the V proteins of simian virus 5 and human parainfluenza virus type 2, respectively: consequences for virus replication in the presence of alpha/beta and gamma interferons | Q39748096 | ||
| STAT3 ubiquitylation and degradation by mumps virus suppress cytokine and oncogene signaling | Q39752565 | ||
| STAT protein interference and suppression of cytokine signal transduction by measles virus V protein | Q39787663 | ||
| Role of alpha/beta interferons in the attenuation and immunogenicity of recombinant bovine respiratory syncytial viruses lacking NS proteins | Q39789324 | ||
| Expression of hepatitis C virus proteins interferes with the antiviral action of interferon independently of PKR-mediated control of protein synthesis | Q27469667 | ||
| Expression of hepatitis C virus proteins inhibits signal transduction through the Jak-STAT pathway | Q27469729 | ||
| Inhibition of the protein kinase PKR by the internal ribosome entry site of hepatitis C virus genomic RNA | Q27472970 | ||
| The NPro Product of Bovine Viral Diarrhea Virus Inhibits DNA Binding by Interferon Regulatory Factor 3 and Targets It for Proteasomal Degradation | Q27477650 | ||
| Classical Swine Fever Virus Interferes with Cellular Antiviral Defense: Evidence for a Novel Function of Npro | Q27477664 | ||
| RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates | Q27861007 | ||
| The 3'-end-processing factor CPSF is required for the splicing of single-intron pre-mRNAs in vivo | Q27863699 | ||
| 5'-Triphosphate RNA is the ligand for RIG-I | Q28131726 | ||
| Virus interference. I. The interferon | Q28181608 | ||
| Control of the interferon-induced 68-kilodalton protein kinase by the HIV-1 tat gene product | Q28244407 | ||
| RNase L inhibitor (RLI) antisense constructions block partially the down regulation of the 2-5A/RNase L pathway in encephalomyocarditis-virus-(EMCV)-infected cells | Q28609293 | ||
| Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. | Q28609759 | ||
| Cellular antiviral responses against influenza A virus are countered at the posttranscriptional level by the viral NS1A protein via its binding to a cellular protein required for the 3' end processing of cellular pre-mRNAS | Q28609773 | ||
| A recombinant influenza A virus expressing an RNA-binding-defective NS1 protein induces high levels of beta interferon and is attenuated in mice | Q28609778 | ||
| Influenza virus NS1 protein inhibits pre-mRNA splicing and blocks mRNA nucleocytoplasmic transport | Q28609810 | ||
| RNase L inhibitor is induced during human immunodeficiency virus type 1 infection and down regulates the 2-5A/RNase L pathway in human T cells | Q28610868 | ||
| Influenza A Virus Lacking the NS1 Gene Replicates in Interferon-Deficient Systems | Q29039793 | ||
| Stats: transcriptional control and biological impact | Q29547776 | ||
| Interferons: cell signalling, immune modulation, antiviral response and virus countermeasures | Q29618978 | ||
| Replication of modified vaccinia virus Ankara in primary chicken embryo fibroblasts requires expression of the interferon resistance gene E3L. | Q33187731 | ||
| TFIIH transcription factor, a target for the Rift Valley hemorrhagic fever virus. | Q33198557 | ||
| Recombinant respiratory syncytial virus that does not express the NS1 or M2-2 protein is highly attenuated and immunogenic in chimpanzees | Q33605207 | ||
| Functional analysis of human herpesvirus 8-encoded viral interferon regulatory factor 1 and its association with cellular interferon regulatory factors and p300. | Q33649357 | ||
| Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein | Q33659093 | ||
| Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3. | Q33781480 | ||
| Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor | Q33784902 | ||
| Attenuated, replication-competent herpes simplex virus type 1 mutant G207: safety evaluation of intracerebral injection in nonhuman primates. | Q33816579 | ||
| Inhibition of PKR activation by the proline-rich RNA binding domain of the herpes simplex virus type 1 Us11 protein | Q33827148 | ||
| The leader protein of Theiler's virus inhibits immediate-early alpha/beta interferon production | Q33853304 | ||
| Tat-responsive region RNA of human immunodeficiency virus 1 can prevent activation of the double-stranded-RNA-activated protein kinase | Q33886447 | ||
| Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach | Q33895154 | ||
| Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus | Q33908950 | ||
| The vaccinia virus K3L gene product potentiates translation by inhibiting double-stranded-RNA-activated protein kinase and phosphorylation of the alpha subunit of eukaryotic initiation factor 2 | Q33930433 | ||
| Inhibition of interferon-mediated antiviral responses by influenza A viruses and other negative-strand RNA viruses | Q33932047 | ||
| Cytopathogenesis and inhibition of host gene expression by RNA viruses | Q34010277 | ||
| Human influenza viruses activate an interferon-independent transcription of cellular antiviral genes: outcome with influenza A virus is unique | Q34099139 | ||
| Protection from interferon-induced apoptosis by Epstein-Barr virus small RNAs is not mediated by inhibition of PKR. | Q34142897 | ||
| VSV strains with defects in their ability to shutdown innate immunity are potent systemic anti-cancer agents | Q34273164 | ||
| Attenuated multi–mutated herpes simplex virus–1 for the treatment of malignant gliomas | Q34297434 | ||
| Blockade of interferon induction and action by the E3L double-stranded RNA binding proteins of vaccinia virus. | Q34337534 | ||
| Vesicular stomatitis virus infection alters the eIF4F translation initiation complex and causes dephosphorylation of the eIF4E binding protein 4E-BP1 | Q34348314 | ||
| The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response | Q34353443 | ||
| Reovirus therapy of tumors with activated Ras pathway | Q34479740 | ||
| Vaccination of pigs against swine influenza viruses by using an NS1-truncated modified live-virus vaccine | Q34561944 | ||
| The primary function of RNA binding by the influenza A virus NS1 protein in infected cells: Inhibiting the 2'-5' oligo (A) synthetase/RNase L pathway | Q34598589 | ||
| Differentially regulated interferon response determines the outcome of Newcastle disease virus infection in normal and tumor cell lines | Q34648125 | ||
| Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling | Q34648134 | ||
| Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation | Q34648461 | ||
| Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication | Q34717075 | ||
| Bunyamwera bunyavirus nonstructural protein NSs counteracts the induction of alpha/beta interferon. | Q35000433 | ||
| Rinderpest virus blocks type I and type II interferon action: role of structural and nonstructural proteins | Q35023714 | ||
| Viruses and the type I interferon antiviral system: induction and evasion | Q35027514 | ||
| The pathogenic NY-1 hantavirus G1 cytoplasmic tail inhibits RIG-I- and TBK-1-directed interferon responses | Q35101310 | ||
| Murine cytomegalovirus m142 and m143 are both required to block protein kinase R-mediated shutdown of protein synthesis | Q35101535 | ||
| The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. | Q35105093 | ||
| Neutralizing innate host defenses to control viral translation in HSV-1 infected cells | Q35613824 | ||
| Vaccinia, cowpox, and camelpox viruses encode soluble gamma interferon receptors with novel broad species specificity | Q35843985 | ||
| The vesicular stomatitis virus matrix protein inhibits transcription from the human beta interferon promoter | Q35874889 | ||
| The gamma(1)34.5 protein of herpes simplex virus 1 complexes with protein phosphatase 1alpha to dephosphorylate the alpha subunit of the eukaryotic translation initiation factor 2 and preclude the shutoff of protein synthesis by double-stranded RNA- | Q35964369 | ||
| Inverse interference: how viruses fight the interferon system | Q36020589 | ||
| Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses | Q36096753 | ||
| The interferon response circuit: induction and suppression by pathogenic viruses | Q36346824 | ||
| Type 1 interferons and the virus-host relationship: a lesson in détente . | Q36475884 | ||
| Inhibition of PKR by RNA and DNA viruses | Q36480640 | ||
| Adenovirus virus-associated RNA and translation control | Q36820396 | ||
| A cytomegalovirus inhibitor of gamma interferon signaling controls immunoproteasome induction | Q36960167 | ||
| Herpes simplex virus 1 gene products occlude the interferon signaling pathway at multiple sites | Q37094247 | ||
| Immunogenicity and protection efficacy of replication-deficient influenza A viruses with altered NS1 genes. | Q37596474 | ||
| Human herpesvirus 8 encodes an interferon regulatory factor (IRF) homolog that represses IRF-1-mediated transcription. | Q38341017 | ||
| P433 | issue | 6-7 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 836-842 | |
| P577 | publication date | 2007-01-27 | |
| P1433 | published in | Biochimie | Q2904035 |
| P1476 | title | Viral suppression of the interferon system | |
| P478 | volume | 89 |
| Q41898857 | A Kaposi's sarcoma-associated herpesvirus protein that forms inhibitory complexes with type I interferon receptor subunits, Jak and STAT proteins, and blocks interferon-mediated signal transduction |
| Q37142893 | Age-related gene expression in Tourette syndrome |
| Q36554219 | An overlapping protein-coding region in influenza A virus segment 3 modulates the host response |
| Q38133428 | BamHI-A rightward frame 1, an Epstein-Barr virus-encoded oncogene and immune modulator. |
| Q21135293 | Broad-spectrum antiviral therapeutics |
| Q38613824 | Bunyaviruses and the type I interferon system |
| Q38985001 | Cell entry of lymphocytic choriomeningitis virus is restricted in myotubes |
| Q36845620 | Cellular La protein shields nonsegmented negative-strand RNA viral leader RNA from RIG-I and enhances virus growth by diverse mechanisms. |
| Q33618390 | Combination antiretroviral therapy (cART) restores HIV-1 infection-mediated impairment of JAK-STAT signaling pathway. |
| Q40357292 | Comparison of antiviral activity of recombinant and natural interferons against crimean-congo hemorrhagic Fever virus |
| Q42204777 | Equine herpesvirus type 1 pUL56 modulates innate responses of airway epithelial cells. |
| Q107392235 | Extracellular vesicles carry SARS-CoV-2 spike protein and serve as decoys for neutralizing antibodies |
| Q33758017 | FAS-associated factor-1 positively regulates type I interferon response to RNA virus infection by targeting NLRX1. |
| Q38613608 | HCV innate immune responses |
| Q38032237 | Herpesviral infection and Toll-like receptor 2 |
| Q34031372 | Human metapneumovirus inhibits IFN-β signaling by downregulating Jak1 and Tyk2 cellular levels |
| Q38060973 | Identification and utility of innate immune system evasion mechanisms of ASFV. |
| Q100385804 | Identification of a herpes simplex virus 1 gene encoding neurovirulence factor by chemical proteomics |
| Q24611465 | Inhibition of the type I interferon response in human dendritic cells by dengue virus infection requires a catalytically active NS2B3 complex |
| Q42702857 | Innate immune modulation in EBV infection |
| Q37102729 | Interferon and cytokine responses to SARS-coronavirus infection |
| Q34536954 | Interferon antagonist NSs of La Crosse virus triggers a DNA damage response-like degradation of transcribing RNA polymerase II. |
| Q40930897 | Interferon induction by avian reovirus |
| Q38199917 | Molecular mechanisms enhancing the proteome of influenza A viruses: an overview of recently discovered proteins. |
| Q39195523 | NSs protein of rift valley fever virus induces the specific degradation of the double-stranded RNA-dependent protein kinase |
| Q37037317 | Neuroimmunology of central nervous system viral infections: the cells, molecules and mechanisms involved. |
| Q37703657 | Neurons under viral attack: victims or warriors? |
| Q37763996 | Non-cytotoxic antiviral activities of granzymes in the context of the immune antiviral state. |
| Q36229509 | Nonstructural Protein 11 of Porcine Reproductive and Respiratory Syndrome Virus Suppresses Both MAVS and RIG-I Expression as One of the Mechanisms to Antagonize Type I Interferon Production |
| Q33924457 | Porcine type I interferons: polymorphic sequences and activity against PRRSV. |
| Q90244937 | R195K mutation in the PA-X protein increases the virulence and transmission of influenza A virus in mammalian hosts |
| Q30413201 | Regulatory, biosafety and safety challenges for novel cells as substrates for human vaccines |
| Q33886159 | Respiratory syncytial virus interferon antagonist NS1 protein suppresses and skews the human T lymphocyte response |
| Q42207575 | Respiratory syncytial virus nonstructural proteins decrease levels of multiple members of the cellular interferon pathways |
| Q38756727 | Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells. |
| Q43760613 | Severe acute respiratory syndrome coronavirus elicits a weak interferon response compared to traditional interferon-inducing viruses |
| Q40090304 | Severe acute respiratory syndrome coronavirus evades antiviral signaling: role of nsp1 and rational design of an attenuated strain |
| Q33401401 | Suppression of the interferon and NF-κB responses by severe fever with thrombocytopenia syndrome virus |
| Q39551895 | The ADP-ribose-1''-monophosphatase domains of severe acute respiratory syndrome coronavirus and human coronavirus 229E mediate resistance to antiviral interferon responses |
| Q40431736 | The activation of the IFNβ induction/signaling pathway in porcine alveolar macrophages by porcine reproductive and respiratory syndrome virus is variable |
| Q34055431 | Tick-borne encephalitis virus delays interferon induction and hides its double-stranded RNA in intracellular membrane vesicles |
| Q24337813 | Toscana virus NSs protein inhibits the induction of type I interferon by interacting with RIG-I |
| Q37652531 | Type I interferons as mediators of immune adjuvants for T- and B cell-dependent acquired immunity |
| Q42093151 | Vaccinia virus-mediated inhibition of type I interferon responses is a multifactorial process involving the soluble type I interferon receptor B18 and intracellular components |
Search more.